GSW_in_ICU: Epidemiology of Gunshot Wounds Injuries Admitted in ICU in France

Sponsor
Centre Hospitalier Universitaire de Nīmes (Other)
Overall Status
Completed
CT.gov ID
NCT05224570
Collaborator
(none)
120
1
77.9
1.5

Study Details

Study Description

Brief Summary

In civilian practice, the incidence of firearm violence depends on the country. In high income countries, most cases are reported in the USA or South Africa. In these countries, gunshot wounds (GSW) represent 20% of death cases in trauma centers, more than motor vehicle collisions.

The mortality in civilian practice occurs during the first 24 hours following GSW, mainly due to hemorrhage and traumatic brain injury, though long term effects on physical and psychological outcomes have also been shown.

Some factors of mortality specific to GSW have been established: multiples wounds, homicide vs suicide attempt, impact zone, or firearm caliber.

Few specific guidelines have been published concerning civilian GSW management. These cases are mostly treated in standard guidelines, such as hemorrhagic shock or traumatic brain injury guidelines. As in other trauma mechanisms, the "platinum ten minutes and golden hour" concept is applicable.

In Europe, the incidence of civilian GSW is much lower and few European studies have been published recently. Penetrating injuries in Europe are less likely to be GSW, and are more often self-inflicted than in the USA. In addition, European studies are heterogeneous, due to the difference in populations, healthcare systems and GSW being grouped with stabbing wounds under the label "penetrating trauma".

However, there is a global concern in Europe regarding a potential rise of GSW, with higher severity score than conventional trauma patients and often necessitate ICU admission. Studies analyzing data from different European countries show significantly different ICU admission rates for overall GSW, ranging from 17% up to 30%.

Therefore, the investigators conducted a multicenter, retrospective study on four French University Hospitals aiming to describe the epidemiology (mortality and type of organ damage) and identify prognosis factors of civilian GSW admitted in ICU.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    120 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Epidemiology of Gunshot Wounds Injuries Admitted in Intensive Care Unit in France: a Retrospective Multicenter Observational Study
    Actual Study Start Date :
    Jan 1, 2015
    Actual Primary Completion Date :
    Jun 30, 2021
    Actual Study Completion Date :
    Jun 30, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    Gunshot wounds admitted in ICU

    patient with Gunshot wounds admitted to ICU

    Outcome Measures

    Primary Outcome Measures

    1. Mortality [day 28]

      mortality rate at day 28 of patients admitted for Gunshot wounds

    Secondary Outcome Measures

    1. Age [Day 0]

      To identify if age is a prognosis factors of mortality of patients admitted for Gunshot

    2. Sex [Day 0]

      To identify if sex is a prognosis factors of mortality of patients admitted for Gunshot

    3. Comorbidity [Day 0]

      To identify if some comorbidities are some prognosis factors of mortality of patients admitted for Gunshot wounds (age, sex, comorbidity, type of gunshot, bullet impact zone, delay to reach hospital, biological parameters at ICU admission, use of antibiotics, blood transfusion, type of surgery, medical management, initiation of renal replacement therapy, length of ICU stay, ).

    4. Type of gunshot [Day 0]

      To identify if the type of gunshot is prognosis factors of mortality of patients admitted for Gunshot wounds

    5. Bullet impact zone [Day 0]

      To identify if the impact zone is a prognosis factors of mortality of patients admitted for Gunshot wounds

    6. Delay to reach hospital [Day 0]

      To identify if the delay to reach hospital is a prognosis factors of mortality of patients admitted for Gunshot wounds

    7. biological parameters at ICU admission [Day 0]

      To identify if some biological parameters at admission are prognosis factors of mortality of patients admitted for Gunshot wounds

    8. antibiotics cure [Day 0]

      To identify if an antibiotic cure at admission is a prognosis factors of mortality of patients admitted for Gunshot wounds

    9. Blood transfusion [Day 0 to day 30]

      To identify if a blood transfusion is a prognosis factors of mortality of patients admitted for Gunshot wounds

    10. Type of surgery [Day 0 to day 30]

      To identify if surgery type is a prognosis factors of mortality of patients admitted for Gunshot wounds

    11. renal replacement therapy [Day 0 to day 30]

      To identify if initiation of renal replacement therapy is a prognosis factors of mortality of patients admitted for Gunshot wounds

    12. length of ICU stay [Day 0 to day 30]

      To identify if length of ICU stay is a prognosis factors of mortality of patients admitted for Gunshot wounds

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    15 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Admission for gunshot wound care in ICU between 1st of January 2015 and June 30th 2021 at Nimes University Hospital, Marseille North University Hospital, Montpellier University Hospital, Toulon Military Teaching Hospital.

    • Patient ≥ 15 years old

    Exclusion Criteria:
    • Patient < 15 years old

    • Patient who objected to the use of their data.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 CHU de NIMES Nimes France 30029

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Nīmes

    Investigators

    • Principal Investigator: Loic ROUGERIE, CHU NIMES
    • Study Director: Laurent MULLER, Md, PhD, CHU NIMES

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire de Nīmes
    ClinicalTrials.gov Identifier:
    NCT05224570
    Other Study ID Numbers:
    • LOCAL/2021/LR-01
    First Posted:
    Feb 4, 2022
    Last Update Posted:
    Feb 4, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 4, 2022